Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...

Kalaris Therapeutics, Inc. reported improved Q3'25 results, with a net loss of $11.9M and $77M in cash. Click here to read why KLRS stock is a Buy.

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Temporarily shutting down a "lazy eye" triggers a burst of neuronal activity that reverses the condition in animal ...

George Gibson remembers turning to his wife after a 2015 procedure at a Florida clinic that he thought would help his failing eyesight. At the hotel room where they were staying, he went to open his ...

With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...

In diabetic macular edema, faricimab can improve visual acuity for treatment-naïve eyes or sustain vision for those ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...

Researchers are testing an unconventional way to treat amblyopia, better known as “lazy eye,” by briefly shutting the weaker ...

Peptide injections are one of the latest health trends to go viral on social media. Proponents of these supplements (including wellness influencers and Health Secretary Robert F. Kennedy Jr.) believe ...